MarketPulse

bioavailability

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Nanobiotix Communications Department

Nanobiotix's Nanoprimer Shows Promise in Reducing LNP Toxicity, Boosting Drug Delivery

Nanobiotix presented preclinical data showing its Nanoprimer platform reduces liver toxicity and improves bioavailability of LNP-delivered DNA immunotherapies in mouse models.
NBTXNanotechnologybioavailability
GlobeNewswire Inc.GlobeNewswire Inc.··Marketsandmarkets

Nutraceutical Excipients Market Poised for 7.4% Growth as Wellness Boom Accelerates

Global nutraceutical excipients market projected to grow 7.4% through 2030, driven by wellness demand and Asia Pacific expansion. Coating agents and modified-release tech lead growth.
BASFYINGRKRYAYIFFSXT+1Asia Pacific growthbioavailability
GlobeNewswire Inc.GlobeNewswire Inc.··Tonix Pharmaceuticals

Tonix's TONMYA Shows Strong Pharmacokinetics Data as First New Fibromyalgia Treatment in 15 Years Gains Traction

Tonix Pharmaceuticals publishes peer-reviewed pharmacokinetic data for TONMYA, the first new fibromyalgia treatment in 15 years, showing rapid absorption and superior bioavailability.
TNXPFDA approvalclinical trial
BenzingaBenzinga··Prnewswire

Rebelution Powers Best 365 Labs' Amazon Expansion Ahead of Major Exchange Uplist

Rebelution partners with Best 365 Labs to scale NAD optimization products on Amazon, supporting parent company's push toward major exchange listing from OTC markets.
BHICbioavailabilitye-commerce partnership
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Novo Nordisk Licenses Vivtex Technology for Oral Obesity and Diabetes Treatments

Novo Nordisk licenses Vivtex's oral drug-delivery technology for obesity and diabetes treatments, with potential $2.1B in milestone payments to develop oral alternatives to injectable biologics.
NVOpartnershipobesity treatment